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Background
Cerebrospinal fluid (CSF) total tau protein (tT) is
increased in Alzheimer's disease (AD) and it has been pro-
posed as a diagnostic marker of AD, useful in the work-up
of demented patients. The aim of the present study was to
investigate the diagnostic aid of tT in terms of every day
practice in the differential diagnosis of AD from other
dementing neuropsychiatric disorders.
Materials and methods
Double-sandwich ELISA (Innotest htau antigen, Innoge-
netics, Belgium) was used to quantify tT in 61 healthy
controls, 62 patients with AD, 27 patients with vascular
dementia (VD), 20 patients with alcohol-related cognitive
disorder (ARCD), 10 patients with depression, 7 with
frontotemporal dementia (FTD) and 12 patients with
Dementia with Lewy bodies (DLB) or Parkinson's disease
with dementia (PDD).
Results
Total tau was always helpful in the differential diagnosis
of AD from normal aging or depression and a positive test
(increased tT) almost confirmed, while a negative test
almost excluded AD diagnosis. In the differential diagno-
sis from ARCD a positive test always confirmed the diag-
nosis of AD, while normal tT was helpful (excluded AD)
only in cases with low clinical probability for AD. In the
differential diagnosis from synucleinopathic or vascular
dementia, when the "probable" NINCDS-ADRDA criteria
were met, the help of tT was little, but when the "possible"
criteria were met a positive test raised the confidence of
AD diagnosis at least to "probable" levels, while a negative
test was usually also of some aid. When the case was
doubtful, a negative test almost excluded AD diagnosis.
However in the differential diagnosis of AD from FTD, the
discriminating value of tT was inadequate.
Discussion
CSF tT may offer significant additional information over
that of clinical criteria of AD, for the discrimination of AD
from normal ageing, depression, ARCD, synucleinopathic
dementia and, possibly, VD. However, for the differential
diagnosis from FTD, the diagnostic help of tT is limited.
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